These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35209175)

  • 41. Rational design of a minimal and highly enriched CYP102A1 mutant library with improved regio-, stereo- and chemoselectivity.
    Seifert A; Vomund S; Grohmann K; Kriening S; Urlacher VB; Laschat S; Pleiss J
    Chembiochem; 2009 Mar; 10(5):853-61. PubMed ID: 19222039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
    Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
    Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
    J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
    Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
    J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promising properties of cytochrome P450 BM3 reconstituted from separate domains by split intein.
    Yoo SK; Cheong DE; Yoo HS; Choi HJ; Nguyen NA; Yun CH; Kim GJ
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132793. PubMed ID: 38830492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of Synthetic cyp102A1-LG23 Gene and Functional Analysis of Recombinant Cytochrome P450 BM3-LG23 in the Actinobacterium Mycolicibacterium smegmatis.
    Poshekhontseva VY; Strizhov NI; Karpov MV; Nikolaeva VM; Kazantsev AV; Sazonova OI; Shutov AA; Donova MV
    Biochemistry (Mosc); 2023 Sep; 88(9):1347-1355. PubMed ID: 37770401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
    Dezvarei S; Lee JHZ; Bell SG
    Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
    Joyce MG; Girvan HM; Munro AW; Leys D
    J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3.
    Kim DH; Ahn T; Jung HC; Pan JG; Yun CH
    Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dimer Stabilization by SpyTag/SpyCatcher Coupling of the Reductase Domains of a Chimeric P450 BM3 Monooxygenase from Bacillus spp. Improves its Stability, Activity, and Purification.
    Essert A; Castiglione K
    Chembiochem; 2024 Feb; 25(3):e202300650. PubMed ID: 37994193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
    Cha GS; Ryu SH; Ahn T; Yun CH
    Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
    de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
    J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.
    Girvan HM; Seward HE; Toogood HS; Cheesman MR; Leys D; Munro AW
    J Biol Chem; 2007 Jan; 282(1):564-72. PubMed ID: 17077084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
    Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
    Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding uncoupling in the multiredox centre P450 3A4-BMR model system.
    Degregorio D; Sadeghi SJ; Di Nardo G; Gilardi G; Solinas SP
    J Biol Inorg Chem; 2011 Jan; 16(1):109-16. PubMed ID: 20857167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of CO binding to P450 BM3 F393 mutants on electron density distribution in the heme cofactor.
    Schelvis JPM; Chen Z; Messina MA; Catalano J
    J Inorg Biochem; 2024 Oct; 259():112660. PubMed ID: 39002177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering.
    Sun Y; Huang X; Osawa Y; Chen YE; Zhang H
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.